University of Perugia is a public-owned university based in Perugia, Italy. It was founded in 1308, as attested by the Bull issued by Pope Clement V certifying the birth of the Studium Generale.

During the past decade, University Of Perugia conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Of Perugia" #1 sponsor was "University Of Perugia" with 8 trials, followed by "Azienda Ospedaliera di Perugia" with 2 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 1 trials sponsored, "Catholic University of the Sacred Heart" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Of Perugia" #1 collaborator was "Alzheimer Europe" with 1 trials as a collaborator, "Associazione Medici Diabetologi (AMD)" with 1 trials as a collaborator, "Associazione Nazionale Medici Cardiologi Ospedalieri" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "University Of Perugia" are "Acute Myeloid Leukemia" (2 trials), "Stroke" (2 trials), "Trisomy 21" (2 trials), "Acute Lymphoid Leukemia" (1 trials) and "Acute Respiratory Failure" (1 trials). Many other conditions were trialed in "University Of Perugia" in a lesser frequency.

Most popular intervention types in "University Of Perugia" are "Drug" (10 trials), "Other" (4 trials), "Procedure" (3 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Active VITATOPS Tablet (folic acid 2mg, B6 25mg , B12 500ug) or placebo" (1 trials), "Alteplase" (1 trials), "Assisted Ventilation" (1 trials) and "Bladder overdistension" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Of Perugia" are 18 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "University Of Perugia". 1 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in University Of Perugia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University Of Perugia, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 6 trials that are defined as “Not Applicable".

University Of Perugia has several departments that took part in Clinical trials: "Department of Internal Medicine - University of Perugia" - 2 trials